Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
about
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.Australian Multicenter Study of Isolated Limb Infusion for Melanoma.Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions.Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases
P2860
Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Resection of residual disease ...... n advanced extremity melanoma.
@ast
Resection of residual disease ...... n advanced extremity melanoma.
@en
type
label
Resection of residual disease ...... n advanced extremity melanoma.
@ast
Resection of residual disease ...... n advanced extremity melanoma.
@en
prefLabel
Resection of residual disease ...... n advanced extremity melanoma.
@ast
Resection of residual disease ...... n advanced extremity melanoma.
@en
P2093
P2860
P1476
Resection of residual disease ...... n advanced extremity melanoma.
@en
P2093
Douglas S Tyler
Jonathan S Zager
Joyce Wong
Kate J Fisher
Y Ann Chen
P2860
P2888
P304
P356
10.1245/S10434-013-3336-4
P577
2013-10-26T00:00:00Z
P6179
1036129456